. This New Covid Vaccine Could Bring Hope to the Unvaccinated World « JO LEE MAGAZINE

NY TIMES –  The first two vaccines to emerge successfully out of clinical trials, made by Pfizer-BioNTech and by Moderna, were both made of RNA. They both turned out to have efficacy rates about as good as a vaccine could get. In the months that followed, those two RNA vaccines have provided protection to tens of millions of people in some 90 countries. But many parts of the world, including those with climbing death tolls, have had little access to them, in part because they require being kept in a deep freeze. Now a third RNA vaccine may help meet that global need.

Therefore at NY TIMES

World on the Run | Jo Lee Magazine

Comments are closed.